Connect with us

News

Turkish Healthcare Startup RS Research Uses Nanotech To Selectively Destroy Tumors

The startup designed a nanotechnology platform for highly targeted delivery of drugs directly to cancer cells.

Published

on

turkish healthcare startup rs research uses nanotech to selectively destroy tumors
Unsplash

All currently available types of treatment for cancer leave a lot to be desired — both in terms of their effectiveness and side effects. Chemotherapy, for example, is effective at preventing cancer from spreading to other parts of the body and even capable of eliminating it entirely, but it can’t tell the difference between cancer cells and healthy cells. Turkish healthcare startup RS Research strongly believes that it has the recipe for significantly increasing the effectiveness of drug-based cancer treatments like chemotherapy.

The startup designed a nanotechnology platform for highly targeted delivery of drugs directly to cancer cells. The platform is called Sagitta, and the name comes from the Latin word for “arrow.”

“Sagitta platform is a groundbreaking technology approach utilizing Polymer Drug Conjugates to target the tumor with a high payload of cytotoxins; resulting in high efficacy with reduced side-effect profile. In addition to moving our own candidates through clinical development, Sagitta platform is available for co-development projects,” explains RS Research on its website.

In other words, Sagitta allows drugs to do their job with minimal side effects, making it possible to avoid causing damage to healthy cells. If everything goes right, the technology could be used to support cancer treatment in Turkey and beyond as early as 2024.

Also Read: FDA Approves Israeli Cancer-Freezing Technology

Together with other innovative cancer treatments, such as gene therapy, hormone replacement therapy, and immunotherapy, scientists and doctors are gradually expanding the range of treatment options available to cancer patients, and we can only hope that a real cure isn’t too far away.

Not too long ago, the FDA approved an Israeli medical technology after demonstrating its ability to eliminate tumors using new cancer-freezing technology.

The COVID-19 pandemic has greatly accelerated many areas of medical research, and it would be a welcome turn of events if some coronavirus-related findings helped finally defeat cancer.

Advertisement

📢 Get Exclusive Monthly Articles, Updates & Tech Tips Right In Your Inbox!

JOIN 23K+ SUBSCRIBERS

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

News

At I/O 2026, Sundar Pichai Concedes AI Must Deliver Real Value

Gemini 3.5, a personal agent called Spark, agentic shopping, and Android XR eyewear are all aimed at making AI feel useful, not just impressive.

Published

on

at io 2026 sundar pichai concedes ai must deliver real value
Google

Google’s annual I/O developer conference (I/O 2026) has recently become a status update on the same question: can the company turn its AI spending into products people use every day? This year, chief executive Sundar Pichai described Google as being in a phase of hyper progress, while conceding this is the part of the cycle where people want to see real value in the products they use on a day-to-day basis.

The strategy on display was to push agents — AI systems that act on a user’s behalf — into nearly every Google product at once. Search now has an “intelligent search box” that returns generated explainer videos alongside links. Gmail, Docs, YouTube and Maps are gaining their own agent layers, including a Docs Live feature that turns spoken instructions into drafted text with citations.

Two new models, Gemini 3.5 and a cheaper Gemini 3.5 Flash, arrived the same day. Google says 900 million people now use Gemini, and that more than 50 billion images have been generated with it. The pricing tier names are likely to confuse buyers: a new AI Ultra plan launches at $100 a month, while the older Gemini AI Ultra drops from $250 to $200.

The flashier announcements were Gemini Omni, a video generator pitched as a more realistic answer to OpenAI’s discontinued Sora 2, and Gemini Spark, a personal agent that handles recurring tasks across a user’s Google account. A new universal shopping cart lets agents complete purchases across multiple retailers from inside Google itself, placing the company between the merchant and the buyer, and also owning the checkout.

Also Read: DJI Teases Dual-Camera Osmo Pocket 4P For 2026 Launch

Google also confirmed its Android XR eyewear, built with Samsung and frames from Warby Parker and Gentle Monster. Audio-only glasses ship this autumn; a display-equipped version, which would superimpose live translations into the wearer’s field of view, is still in development. Both sets translate, however only the display version shows you the result.

What Pichai did not resolve is the bargain underneath all this. An agent is only useful to the degree it knows your calendar, your inbox, your shopping history and your physical surroundings. Google has now confirmed that, in time, the same context may carry advertising.

Continue Reading

#Trending